Liu F, Nishikawa M, Clemens P R, Huang L
Center for Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
Mol Ther. 2001 Jul;4(1):45-51. doi: 10.1006/mthe.2001.0419.
Mutations in the gene encoding dystrophin, a large cytoskeletal protein in muscle, lead to Duchenne muscular dystrophy (DMD). Affected individuals often die of respiratory failure resulting primarily from diaphragm muscle degeneration. Here we report a new procedure to transfer the full-length dystrophin cDNA into the diaphragm muscle of Dmd(mdx/mdx) mice, which carry a mutation in the dystrophin gene (Dmd). Significant gene transfer was found after intravenous injection of naked plasmid DNA followed by a brief (eight second) occlusion of blood flow at the vena cava. This is the first demonstration of gene transfer into the diaphragm muscle through systemic administration of naked plasmid DNA. The approach has potential application for treatment of DMD.
编码肌营养不良蛋白(一种肌肉中的大型细胞骨架蛋白)的基因突变会导致杜氏肌营养不良症(DMD)。受影响的个体通常死于呼吸衰竭,主要原因是膈肌肌肉退化。在此,我们报告一种将全长肌营养不良蛋白cDNA导入Dmd(mdx/mdx)小鼠膈肌的新方法,这些小鼠的肌营养不良蛋白基因(Dmd)存在突变。静脉注射裸质粒DNA,随后短暂(8秒)阻断腔静脉血流后,发现有显著的基因转移。这是首次通过全身给予裸质粒DNA将基因导入膈肌的证明。该方法在DMD治疗方面具有潜在应用价值。